Alira Health Adds CMC Services through Acquisition of Chamow & Associates

Chamow & Associates’ expertise in biopharmaceutical product development expands Alira Health’s lifecycle of healthcare advisory services.   

News
Published on:
January 7, 2021

FRAMINGHAM, Mass. – January 7, 2021 – Alira Health (www.alirahealth.com), a leading international healthcare and life sciences advisory firm, announced it has acquired Chamow & Associates, a California-based integrated CMC advisory firm. This acquisition brings expertise in biologics manufacturing, quality assurance, and regulatory compliance to Alira Health’s Product Development and Regulatory practices, which now offer a full range of services, from discovery to approval, across the U.S. and EU. Chamow & Associates’ Team of Senior Advisors complement Alira Health’s existing offerings with expertise to help clients overcome CMC challenges throughout the development process.

Gabriele Brambilla

“Our mission at Alira Health to enable healthcare transformation and support clients in the earliest stages of development, is critical to efficiently and safely shepherd innovations into the hands of patients,” said Gabriele Brambilla, Chief Executive Officer at Alira Health. Steven Chamow has built a powerful combination of CMC capabilities, technical proficiency, and biologic expertise into his firm. We are proud to welcome them to the Alira Health family, and to offer preclinical and clinical-stage biotechnology companies a lifecycle of solutions to help bring new therapies to patients.”

“We are excited and honored to become part of the Alira Health network, and to join a talented team of experts with a complementary mission,” said Dr. Steven Chamow, President of Chamow & Associates. “Becoming part of the Alira Health family will allow Chamow & Associates to further build our team and greatly expand our work with clients. By adding CMC expertise and advisory to Alira Health’s suite of services, we have a tremendous opportunity to provide comprehensive support to meet the needs of pharmaceutical companies at any stage of the development process.”

 

Steven Chamow will become Alira Health’s Senior Vice President, CMC Development and will lead biopharmaceutical product development.
Lighthouse BioPartners acted as a financial advisor to Chamow & Associates for this transaction.

About Chamow & Associates:
Chamow & Associates is a leading biopharmaceutical consulting company based in the San Francisco Bay Area. Since 2008, the company has provided integrated CMC services, including molecular engineering, process development and manufacturing, quality, regulatory, and project management services, to clinical-stage biotechnology companies around the world. Chamow & Associates focuses on monoclonal antibodies and derivatives, including bispecific antibodies and antibody drug conjugates, in addition to other recombinant protein products.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Mauris urna arcu, tempor ut laoreet eu, consectetur in mi. Maecenas rhoncus velit eget metus dignissim, sed bibendum elit lacinia. Mauris tristique, nisi ac sollicitudin dignissim, dui ipsum suscipit nulla, vitae sodales neque mauris vel est. Duis est velit, efficitur eget rutrum non, interdum et erat. Duis elit arcu, tristique quis feugiat quis, tincidunt tempus ligula. In hac habitasse platea dictumst. Ut dolor neque, egestas quis accumsan at, egestas sit amet leo.

Related news

Events February 21, 2024
XXII Conferenza Nazionale Sulla Farmaceutica
Meet Giovanni Firenze, Partner Consulting Italy, onsite in Catania and learn more about the impact of the new AIFA reform.
Italy Regulatory
Events September 28, 2023
Regulatory Roundup
Look for our clinical development experts Chris Rao and Kenny Carberry as delegates onsite at MassMedic Regulatory Roundup.
MedTech Regulatory
Publications September 22, 2023
Impact of the New EU HTA Regulation on Access to Innovative Medicines in Europe
In this interview, Alira Health Partner Chus Castillo gives updates on HTA Regulation, related challenges, and potential effect on access to innovative medicines.
Biotech Healthcare Technology Regulatory Spain
Publications August 1, 2023
The EU Pharmaceutical Package: Impact on Orphan Medicinal Products
This article reviews the proposed changes in the EU Pharma Package for data protection related to orphan medicinal products (OMPs).
EU Pharma Regulatory
Publications July 11, 2023
Five Years Evolution of Chemotherapy Administration in Home Care in France
Have a look at the poster to get an overview of the dynamics in the development of chemotherapy in home care across different French regions during a five-year period.
Clinical France Outcomes Research
Publications July 10, 2023
The EU Pharmaceutical Package: Regulatory Protection Changes
Our regulatory experts present a more detailed analysis of the proposed changes introduced to Regulatory Data Protection (RDP).
EU Pharma Regulatory
Events June 20, 2023
Advanced Wound Care Summit
We are pleased to announce that we will sponsor, attend, and speak at Advanced Wound Care Summit.
Clinical Clinical Trials Wound Healing
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.